Main navigation

Cardano Founder Dismisses Theranos Comparisons: "We Have No Secrets"

News
Tue, 02/22/2022 - 08:07
article image
Alex Dovbnya
Input Output CEO Charles Hoskinson has explained the key difference between Theranos and Cardano during a recent ask-me-anything session
Cardano Founder Dismisses Theranos Comparisons: "We Have No Secrets"
Cover image via stock.adobe.com
Read U.TODAY on
Google News

During a recent ask-me-anything session, Input Output CEO Charles Hoskinson said that his company has "no secrets" when asked to weigh in on the Theranos disaster.



The Cardano creator claims that the failed biotech company is a great example of a "magic box" that many wanted to work because they needed a "female Steve Jobs," adding that there is no legitimate reason why a real company would not want the general public to test its product:

Anyone in the world can fork Cardano…Anyone in the world can take our paper and implement our papers as has been done by Mina Protocol and Polkadot for some of our papers…There's no restrictions. If you are a scam, you don't let people see what's behind the curtain because there's nothing there. It's just that simple.

The now-defunct darling of Silicon Valley, which was once valued at $9 billion, collapsed after it transpired that its Edison blood-testing machines never actually worked.

Related
Cardano's Charles Hoskinson Denies Buyback Rumors, Threatens Critic with Lawsuit
The high-profile Theranos case has blurred the lines between scammers and visionaries, and founder Elizabeth Holmes has failed to convince the jury with her Svengali defense.

In early January, the former billionaire was found guilty on multiple charges, with her sentencing scheduled to occur on Sept. 26.

Cardano critics often claim that its technology is as real as Theranos's blood tests, accusing the project of being hype-driven vaporware with empty promises and non-existent users.

Hyping up products is not uncommon within the cryptocurrency industry, which seems to be much keener on overpromising than Silicon Valley. The Theranos case shows that ambitious crypto companies have to find the right balance between excessive optimism and honesty.

While Holmes's case might not put a definite end to the prevalent "fake it 'til you make it' culture," it might lead toward more accountability.

article image
About the author

Alex Dovbnya (aka AlexMorris) is a cryptocurrency expert, trader and journalist with extensive experience of covering everything related to the burgeoning industry — from price analysis to Blockchain disruption. Alex authored more than 1,000 stories for U.Today, CryptoComes and other fintech media outlets. He’s particularly interested in regulatory trends around the globe that are shaping the future of digital assets, can be contacted at alex.dovbnya@u.today.